Ali Faraz's Form 4 filing
Tenaya Therapeutics, Inc. (TNYA) · filed Mar 10, 2025
- Accession no.
- 0000950170-25-036770
- Filed
- Mar 10, 2025
- Trade date
- Mar 10, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.26K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ali FarazCIK 0001667937 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | Common Stock | SSaleDisposed | −5,794 | $0.54 | −$3,128.76 | 324,461 | Direct | |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −3,947 | $0.54 | −$2,131.38 | 320,514 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.